Adrenoceptor α2A signalling countervails the taming effects of synchronous cyclic nucleotide-elevation on thrombin-induced human platelet activation and aggregation
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 59, 96-109
Abstract
No abstract availableKeywords
Funding Information
- Knowledge Foundation (20150240)
- AFA Insurance (130275)
This publication has 55 references indexed in Scilit:
- Blockade of the purinergic P2Y 12 receptor greatly increases the platelet inhibitory actions of nitric oxideProceedings of the National Academy of Sciences, 2013
- The platelet P2Y12 receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [3H]PSB-0413Purinergic Signalling, 2012
- Physical, Psychological and Chemical Triggers of Acute Cardiovascular EventsCirculation, 2011
- Adenosine and blood plateletsPurinergic Signalling, 2011
- Thrombin and Collagen Induce a Feedback Inhibitory Signaling Pathway in Platelets Involving Dissociation of the Catalytic Subunit of Protein Kinase A from an NFκB-IκB ComplexJournal of Biological Chemistry, 2010
- Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3ABlood, 2007
- The interaction of sodium nitroprusside with human endothelial cells and platelets: nitroprusside and prostacyclin synergistically inhibit platelet function.Circulation, 1982
- Platelet Function in Essential ThrombocythemiaNew England Journal of Medicine, 1978
- Serial Determination of Plasma Catecholamines in Myocardial InfarctionCirculation, 1972
- Plasma Catechol Amine Concentrations in Myocardial Infarction and Angina PectorisCirculation, 1959